Bayer Chief’s “Cancer Drugs For Western Patients” Remarks Draws Flak In India
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer has sparked controversy in India again with remarks from global chief Marijn Dekkers last month at a health care conference on the compulsory license granted to Nexavar. Health care activists strongly objected to Dekkers calling the move “a theft,” which he later clarified was said out of frustration over the country’s IP laws.